Wyrick Robbins Guiding Citius Oncology Unit In SPAC Merger
Wyrick Robbins Yates & Ponton LLP-led Citius Pharmaceuticals said Tuesday it is planning to merge its oncology-focused subsidiary with blank-check company TenX Keane Acquisition, which is represented by The Crone Law...To view the full article, register now.
Already a subscriber? Click here to view full article